CDEs
Forms
How many times were parenteral opioid drugs required for the painful vaso-occlusive crisis in the outpatient setting during this assessment period?
Date of first occurrence of painful vaso-occlusive crisis requiring hospitalization OR parenteral opioid drugs in the outpatient setting during this assessment period
Did any of the events reported above lead to an advanced care intervention or Intensive Care Unit admission/transfer as outlined in the AE reporting section of chapter 4 of the protocol?
Liver abnormalities
Specify event(s)
Comments
Was prophylaxis for GVHD given during this assessment period?
ATG
Bortezomib
Campath
Cyclophosphamide
Cyclosporine
MMF
Maraviroc
Methotrexate
Prednisone
Sirolimus
Tacrolimus
Other immunosuppressant
Specify other immunosuppressant agent used
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142